efavirenz has been researched along with Extensively Drug-Resistant Tuberculosis in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| de Kock, L; Derendorf, H; Diacon, AH; Donald, PR; Hernandez, KR; Prescott, K; Rosenkranz, B; Sy, SK; Yu, M | 1 |
1 trial(s) available for efavirenz and Extensively Drug-Resistant Tuberculosis
| Article | Year |
|---|---|
Pharmacokinetics of para-aminosalicylic acid in HIV-uninfected and HIV-coinfected tuberculosis patients receiving antiretroviral therapy, managed for multidrug-resistant and extensively drug-resistant tuberculosis.
Topics: Adult; Alkynes; Aminosalicylic Acid; Anti-Retroviral Agents; Antitubercular Agents; Benzoxazines; Cross-Over Studies; Cyclopropanes; Extensively Drug-Resistant Tuberculosis; Female; HIV Infections; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Tuberculosis, Multidrug-Resistant; Young Adult | 2014 |